These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2622040)

  • 1. [Clinical significance of cytochrome b5 reductase analysis in blood cell chemical tests].
    Takeshita M
    Nihon Rinsho; 1989 Dec; 48 Suppl():982-4. PubMed ID: 2622040
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hereditary methemoglobinemia due to NADH cytochrome b5 abnormality--clinical importance of the enzyme in leukocytes and platelets].
    Tomita Y; Inagaki M; Taki M; Miura T; Saito N; Meguro T; Yamada K; Fujii H; Takizawa T; Miwa S
    Rinsho Ketsueki; 1986 Mar; 27(3):412-9. PubMed ID: 3735692
    [No Abstract]   [Full Text] [Related]  

  • 3. NADH-cytochrome b5 reductase in platelets and leukocytes with special reference to normal levels and to levels in carriers of hereditary methemoglobinemia with or without neurological symptoms.
    Tanishima K; Matsuki T; Fukuda N; Takeshita M; Yoneyama Y
    Acta Haematol; 1980; 63(1):7-12. PubMed ID: 6768212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gene analysis and genetic diagnosis of hereditary erythrocyte abnormalities. Cytochrome b5 reductase deficiency].
    Yokota E; Naito Y; Niho Y
    Nihon Rinsho; 1987 Dec; 45(12):2911-6. PubMed ID: 3446879
    [No Abstract]   [Full Text] [Related]  

  • 5. Structural analysis of NADH-cytochrome b5 reductase in relation to hereditary methemoglobinemia.
    Yubisui T; Murakami K; Shirabe K; Takeshita M; Zenno S; Tomatsu S; Fukumaki Y
    Prog Clin Biol Res; 1989; 319():107-19; discussion 120-1. PubMed ID: 2695933
    [No Abstract]   [Full Text] [Related]  

  • 6. Alteration of NADH-diaphorase and cytochrome b5 reductase activities of erythrocytes, platelets, and leucocytes in hereditary methaemoglobinaemia with and without mental retardation.
    Takeshita M; Matsuki T; Tanishima K; Yubisui T; Yoneyama Y; Kurata K; Hara N; Igarashi T
    J Med Genet; 1982 Jun; 19(3):204-9. PubMed ID: 6896729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cell differentiation, maturation and enzyme abnormality--studies on NADH-cytochrome b5 reductase].
    Takeshita M; Yubisui T
    Rinsho Ketsueki; 1986 Jul; 27(7):1138-44. PubMed ID: 3783996
    [No Abstract]   [Full Text] [Related]  

  • 8. [Genetics and biochemistry of NADH-cytochrome b5 reductase deficiency].
    Shirabe K
    Nihon Rinsho; 1999 Sep; 57 Suppl():769-71. PubMed ID: 10543233
    [No Abstract]   [Full Text] [Related]  

  • 9. Serine-proline replacement at residue 127 of NADH-cytochrome b5 reductase causes hereditary methemoglobinemia, generalized type.
    Kobayashi Y; Fukumaki Y; Yubisui T; Inoue J; Sakaki Y
    Blood; 1990 Apr; 75(7):1408-13. PubMed ID: 2107882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymopenic hereditary methemoglobinemia: a clinical/biochemical classification.
    Jaffé ER
    Blood Cells; 1986; 12(1):81-90. PubMed ID: 3539237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and biological forms of cytochrome b5 reductase deficiency].
    Kaplan JC; Leroux A; Beauvais P
    C R Seances Soc Biol Fil; 1979; 173(2):368-79. PubMed ID: 159760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary methemoglobinemia due to cytochrome b5 reductase deficiency in blood cells without associated neurologic and mental disorders.
    Tanishima K; Tanimoto K; Tomoda A; Mawatari K; Matsukawa S; Yoneyama Y; Ohkuwa H; Takazakura E
    Blood; 1985 Dec; 66(6):1288-91. PubMed ID: 4063522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital methemoglobinemia with cytochrome-b5-reductase deficiency: 4th Swiss family].
    Bürgi W; Fischer S; Killer D; Kaufmann H; Gnehm H; Fricker HS
    Schweiz Med Wochenschr; 1989 Sep; 119(39):1355-7. PubMed ID: 2799343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-bound cytochrome b5 reductase (methemoglobin reductase) in human erythrocytes. Study in normal and methemoglobinemic subjects.
    Choury D; Leroux A; Kaplan JC
    J Clin Invest; 1981 Jan; 67(1):149-55. PubMed ID: 7451647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent decay of cytochrome b5 and cytochrome b5 reductase in human erythrocytes.
    Matsuki T; Tamura M; Takeshita M; Yoneyama Y
    Biochem J; 1981 Jan; 194(1):327-30. PubMed ID: 7305986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methemoglobinemias. Cytochrome b5-reductase deficiency].
    Thu DT; Damianova L
    Eksp Med Morfol; 1993; 31(1-2):42-50. PubMed ID: 8258315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration of NADH-cytochrome b5 reductase in erythrocytes of normal and methemoglobinemic individuals measured with a quantitative radioimmunoblotting assay.
    Borgese N; Pietrini G; Gaetani S
    J Clin Invest; 1987 Nov; 80(5):1296-302. PubMed ID: 3680497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary methemoglobinemia with mental retardation and neurologic disorders. Clinical and biochemical study of a case].
    Beauvais P; Leroux A; Kaplan JC
    Nouv Presse Med; 1976 Dec; 5(41):2793-5. PubMed ID: 995609
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytochrome b5 reductase activity in erythrocytes and leukocytes as related to sex and age.
    Panin G; Pernechele M; Giurioli R; Secchieri S; Milanesi O; Pellegrino PA; Chiandetti L
    Clin Chem; 1984 May; 30(5):701-3. PubMed ID: 6713629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetics and biochemistry of NADH-cytochrome b5 reductase].
    Shirabe K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():765-7. PubMed ID: 15658445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.